Back to Search Start Over

Evaluation of human thyroid hormone receptor-antagonist activity in 691 chemical compounds using a yeast two-hybrid assay with Saccharomyces cerevisiae Y190.

Authors :
Omagari R
Yagishita M
Shiraishi F
Kamata R
Terasaki M
Kubo T
Nakajima D
Source :
Data in brief [Data Brief] 2022 May 21; Vol. 42, pp. 108303. Date of Electronic Publication: 2022 May 21 (Print Publication: 2022).
Publication Year :
2022

Abstract

The human thyroid receptor (hTR)-antagonist activities of 691 compounds were evaluated using a yeast two-hybrid assay with Saccharomyces cerevisiae Y190 introduced hTRα and coactivator. In parallel, those YTOX tests were conducted to evaluate whether those compounds affected either antagonism or toxicity. This is the first report that focuses on the hTR-antagonist activity of many chemical compounds suspected to be endocrine disruptor. In this study, 46 compounds exhibited antagonist activity at 50% of the maximum activity (IC × 50) within 11-9940 nM. In particular, 10,10-Oxybisphenoxarsine, triphenyltin fluoride, triphenyltin hydroxide, and chlorothalonil had strong hTR-antagonist activities. This knowledge gained from the present study will boost chemical regulation strategies for human and wildlife health.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2022 The Author(s).)

Details

Language :
English
ISSN :
2352-3409
Volume :
42
Database :
MEDLINE
Journal :
Data in brief
Publication Type :
Academic Journal
Accession number :
35664659
Full Text :
https://doi.org/10.1016/j.dib.2022.108303